Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly (Q33845790)

29 July 2017

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly (English)

1 reference

29 July 2017

1 reference

1 reference

De Donato S

1

1 reference

29 July 2017

Granoff D

2

1 reference

29 July 2017

Minutello M

3

1 reference

29 July 2017

Lecchi G

4

1 reference

29 July 2017

Faccini M

5

1 reference

29 July 2017

Agnello M

6

1 reference

29 July 2017

Senatore F

7

1 reference

29 July 2017

Verweij P

8

1 reference

29 July 2017

Fritzell B

9

1 reference

29 July 2017

Podda A

10

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

29 July 2017

8

1 reference

inferred from page(s)

published in

Vaccine

1 reference

29 July 2017

17

1 reference

29 July 2017

23-24

1 reference

29 July 2017

3094-3101

1 reference

Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

Impact of epidemic type A influenza in a defined adult population

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

Relation of chronic disease and immune response to influenza vaccine in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

Antibody induction by influenza vaccines in the elderly: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

Antigenic drift and efficacy of influenza virus vaccines, 1976--1977

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

Influenza vaccines for the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

1 reference

7 January 2021

MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900138-3

7 January 2021

10.1016/S0264-410X(99)00138-3

Identifiers

DOI

1 reference

29 July 2017

1 reference